From Our Partners
Wednesday, July 6, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

IARPA Seeks Technologies and Methods to Detect Genome Editing

by Global Biodefense Staff
February 1, 2017
Genome Editing Research

The Intelligence Advanced Research Projects Activity (IARPA) is seeking information on potential tools and methods that can be used to detect evidence of genome editing in biological organisms, including viruses.

While genome editing technology will enable new biological breakthroughs, the unintentional or deliberate misuse of genome editing tools may have adverse economic, health, and national security implications.

The fundamental components of many genome editing tools are found in nature, so detection requires an ability to distinguish engineered organisms from naturally-occurring background.

Areas of interest include:

  • Research aimed at identifying direct or indirect signatures of genome editing in biological organisms
  • Applications associated with edited microorganisms, plants and animals, especially those of economic importance or those that serve as infectious disease reservoirs
  • Research efforts, including those in genomics, proteomics and metabolomics, that can better distinguish organisms that are engineered from those that occur naturally
  • Scalable or high-throughput approaches for detection of organisms, that, if altered, have health or economic implications
  • Methods to estimate the longitudinal stability of modifications once moved from a laboratory setting to the environment, and factors that determine if a modification is entirely lost or if markers of the modification still exist
  • Methods for predicting or anticipating environmental effects resulting from a release of an engineered organism; and determination of provenance of genome editing tools and techniques

IARPA requests that respondents submit ideas related to this topic for use by the government in formulating a potential program. Statements should briefly and clearly describe the potential approach or concept, outline critical technical issues, describe how the approach may address those issues/obstacles and comment on the expected performance and robustness of the proposed approach.

Further details are available via Solicitation Number: IARPA-RFI-17-02. The response deadline is March 3, 2017.

Editor also recommends:

  • Gene drives thwarted by emergence of resistant organisms (Nature)
  • It’s time to modernize the bioweapons convention (BOTAS)
  • Obama’s Science Advisors Are Worried About Future CRISPR Terrorism (Motherboard)
  • The future of genome editing and how it will be regulated (Phys.org)
  • Gene drives: The good, the bad, and the hype (BOTAS)
From Our Partners
Tags: CRISPREmerging ThreatsRFI

Related Posts

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance
Biosurveillance

The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance

June 9, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
Load More

Latest News

Biodefense Headlines – 5 July 2022

Biodefense Headlines – 5 July 2022

July 5, 2022
Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC